Your medical briefing

Stay current.
Stay focused.

Research, guidelines, and safety alerts for your specialty.

All specialties Internal Medicine Family Medicine Pediatrics Cardiology Oncology Endocrinology Surgery

Gynecology & Obstetrics

Recent updates in Gynecology & Obstetrics from the last 30 days.

AllAll updates Research Guidelines Safety alerts

A randomized, pragmatic trial in nulliparous patients with term singleton pregnancies compared directed hip extension at crowning with usual, undirected positioning during vaginal delivery. In the intention-to-treat analysis, rates of significant perineal lacerations were similar between groups (66.6% vs 66.2%), though an as-treated analysis (with 25% nonadherence in the intervention group) showed lower unadjusted rates of significant lacerations and obstetric anal sphincter injuries with extension, differences that were not significant after adjustment. The trial concluded that hip extension did not reduce significant perineal lacerations at term vaginal delivery.

Stay current.
Stay focused.

Gynecology & Obstetrics

Hip Extension at Crowning Did Not Reduce Perineal Lacerations

RFA and myomectomy show similar symptom relief for fibroids at 2 years

Antihypertensive escalation tied to higher maternal risk in preeclampsia

Injectable HIV therapy outperforms daily pills in adolescents in trial

Intrauterine mepivacaine reduced pain during IUD placement in trial

Whole Blood Shows No Survival Edge, Raising RhD Transfusion Concerns

Clinical Perspective Offers Toolkit for Hormonal Management of Perimenopause

Azithromycin Use Rose, Postpartum Infections Fell After Cesarean Trial

Episiotomy type linked to differing anal sphincter injury risk in operative delivery

Class II recall: Baxter Healthcare Corporation: Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg

Class II recall: Baxter Healthcare Corporation: Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Sin

Class II recall: Baxter Healthcare Corporation: Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50

Class I recall: OPTIMAL BALANCE PHARMACY: Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutath

Class I recall: Baxter Healthcare Corporation: 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 u

Class I recall: Fresenius Kabi USA, LLC: Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Onl

Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count b

Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Onl

Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx On

Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only

Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bot

Stay current. Stay focused.

Stay current.
Stay focused.